Global Cell and Gene Therapy Manufacturing QC Market Expected to Reach $10.65 Billion by 2033, Witnessing a CAGR of 16.85% - ResearchAndMarkets.com
The "Cell and Gene Therapy Manufacturing QC Market - A Global and Regional Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.
- The "Cell and Gene Therapy Manufacturing QC Market - A Global and Regional Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.
- The global cell and gene therapy manufacturing QC market was valued at $1.95 billion in 2022 and is projected to reach $10.65 billion by 2033, with a CAGR of 16.85% during the forecast period from 2023 to 2033.
- The demand for QC in cell and gene therapy manufacturing is driven by the growing production of therapies and increasing approvals for cell and gene therapies.
- The global cell and gene therapy manufacturing QC market is on a growth trajectory, and key players are leveraging advancements in technology to drive improvements in product quality and safety.